The Global Eosinophilic Esophagitis Market Growth Accelerated By Availability Of Targeted Treatment Options

https://www.coherentmarketinsights.com/market-insight/eosinophilic-esophagitis-market-4909
Eosinophilic Esophagitis Market

Eosinophilic esophagitis is a chronic immune/antigen-mediated disease characterized by eosinophil infiltration of the esophageal epithelium resulting in symptoms such as dysphagia, food impaction, and abdominal pain. The disease is increasingly being recognized and requires long-term pharmacologic treatment with proton pump inhibitors or topical corticosteroids to eliminate clinical symptoms.

The global Eosinophilic Esophagitis Market is estimated to be valued at US$ 245.92 million in 2023 and is expected to exhibit a CAGR of 7.1%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The availability of targeted treatment options is accelerating the growth of the Eosinophilic Esophagitis market over the forecast period. Traditionally, topical steroids were used in the treatment of Eosinophilic Esophagitis. However, they are associated with side-effects such as nephrotoxicity, Cushingoid features. Novel targeted biologics offer promising therapeutic benefit and safer treatment options for Eosinophilic Esophagitis with minimal side-effects. For instance, benralizumab, which targets IL-5 receptor, has demonstrated meaningful histologic and symptomatic improvement in phase 3 clinical trials. With the FDA approval of targeted biologics such as benralizumab and mepolizumab, the treatment landscape for Eosinophilic Esophagitis is evolving rapidly thereby increasing market growth.


Segment Analysis
Eosinophilic Esophagitis Market is segmented based on drug class into corticosteroids, proton pump inhibitors (PPIs), and biologics. The biologics sub-segment dominates the market as biologics specifically target eosinophils for treatment. Drugs like Dupixent have received FDA approval for treating eosinophilic esophagitis and thus drive growth of this sub-segment.

Key Takeaways
The global Eosinophilic Esophagitis Market Growth is expected to witness high growth over the forecast period of 2023 to 2030. The global Eosinophilic Esophagitis Market is estimated to be valued at US$ 245.92 million in 2023 and is expected to exhibit a CAGR of 7.1%  over the forecast period 2023 to 2030.

North America is expected to be the fastest growing region for the Eosinophilic Esophagitis Market owing to rising prevalence rates and strong presence of key biotech companies developing biologics in the region. The region currently dominates the global market as well.

Key players related content comprises
Key players operating in the Eosinophilic Esophagitis Market are Adare Pharmaceuticals, Inc., Cipla Limited, GlaxoSmithKline PLC, and TEVA Pharmaceutical Industries Ltd.

Check below Healthcare related articles on this topic: https://www.pressreleasebulletin.com/rising-incidences-of-eosinophilic-esophagitis-to-boost-therapeutic-development/

https://filmik.in/cell-therapy-harmonizing-hope-through-the-therapeutic-rhythm-of-cellular-alchemy/

Comments

Post a Comment

Popular posts from this blog

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Image
Dairy Alternative Market Market Overview: Dairy alternative products are gaining significant popularity due to their numerous advantages. These products are plant-based, making them suitable for individuals with lactose intolerance or those following a vegan diet. They offer similar nutritional benefits as traditional dairy products such as milk, cheese, and yogurt, while also addressing concerns related to animal welfare and environmental sustainability. The growing demand for dairy alternative products among health-conscious consumers is driving market growth. Market Key Trends: One key trend observed in the dairy alternative market is the increasing preference for plant-based milk substitutes. Plant-based milk alternatives such as almond milk, soy milk, and oat milk, among others, are gaining traction among consumers as a healthier and more sustainable option compared to traditional dairy milk. These plant-based milk alternatives offer various benefits such as being lactose-free, c...
Read more

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries

Image
Antimicrobial Additives Market Antimicrobial additives are extensively used in a wide range of end-use industries such as healthcare, packaging, food and beverage, construction, and automotive. These additives help protect various materials from microorganisms such as bacteria, viruses, etc. Some key applications of antimicrobial additives include packaging of food, medical devices, fabrics, flooring, coatings, etc. The ongoing COVID-19 pandemic has further increased the importance of hygiene and sanitation, driving demand for antimicrobial materials from various sectors. The global Antimicrobial Additives Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 25.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key drivers of the market's growth is the rising demand for antimicrobial additives from the packaging industry. Packaging manufacturers ...
Read more